BG104397A - Extended release formulation - Google Patents

Extended release formulation

Info

Publication number: BG104397A
Authority: BG; Bulgaria
Prior art keywords: extended release; provides; release formulation; venlafaxine hydrochloride; antidepressant
Prior art date: 1997-11-05

Application number

BG104397A

Other languages

Bulgarian (bg)

English (en)

Inventor

Deborah M. Sherman

John C. Clark

John U. Lamer

Original Assignee

American Home Products Corp.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-11-05

Filing date

2000-05-04

Publication date

2001-02-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25508423&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG104397(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-05-04 Application filed by American Home Products Corp. filed Critical American Home Products Corp.

2001-02-28 Publication of BG104397A publication Critical patent/BG104397A/xx

Links

238000013265 extended release Methods 0.000 title abstract 3
238000009472 formulation Methods 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
229960002416 venlafaxine hydrochloride Drugs 0.000 abstract 2
QYRYFNHXARDNFZ-UHFFFAOYSA-N venlafaxine hydrochloride Chemical compound [H+].[Cl-].C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 QYRYFNHXARDNFZ-UHFFFAOYSA-N 0.000 abstract 2
229920000168 Microcrystalline cellulose Polymers 0.000 abstract 1
206010047700 Vomiting Diseases 0.000 abstract 1
230000001430 anti-depressive effect Effects 0.000 abstract 1
239000000935 antidepressant agent Substances 0.000 abstract 1
229940005513 antidepressants Drugs 0.000 abstract 1
230000037058 blood plasma level Effects 0.000 abstract 1
239000002552 dosage form Substances 0.000 abstract 1
239000001866 hydroxypropyl methyl cellulose Substances 0.000 abstract 1
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 abstract 1
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 abstract 1
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 abstract 1
235000019813 microcrystalline cellulose Nutrition 0.000 abstract 1
239000008108 microcrystalline cellulose Substances 0.000 abstract 1
229940016286 microcrystalline cellulose Drugs 0.000 abstract 1
239000007916 tablet composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Emergency Medicine (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BG104397A 1997-11-05 2000-05-04 Extended release formulation BG104397A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US96432897A	1997-11-05	1997-11-05
PCT/US1998/023338 WO1999022724A2 (fr)	1997-11-05	1998-11-03	Preparation a liberation prolongee

Publications (1)

Publication Number	Publication Date
BG104397A true BG104397A (en)	2001-02-28

Family

ID=25508423

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG104397A BG104397A (en)	1997-11-05	2000-05-04	Extended release formulation

Country Status (38)

Country	Link
EP (1)	EP1028718B1 (fr)
JP (1)	JP2001521892A (fr)
KR (1)	KR20010031797A (fr)
CN (1)	CN1278165A (fr)
AR (1)	AR014012A1 (fr)
AT (1)	ATE237320T1 (fr)
AU (1)	AU747978B2 (fr)
BG (1)	BG104397A (fr)
BR (1)	BR9813179A (fr)
CA (1)	CA2305242A1 (fr)
CL (1)	CL2004001705A1 (fr)
CO (1)	CO5011060A1 (fr)
CZ (1)	CZ20001659A3 (fr)
DE (1)	DE69813602T2 (fr)
DK (1)	DK1028718T3 (fr)
EA (1)	EA200000487A1 (fr)
EE (1)	EE04577B1 (fr)
ES (1)	ES2196620T3 (fr)
GE (1)	GEP20043198B (fr)
HR (1)	HRP20000213B1 (fr)
HU (1)	HU225238B1 (fr)
ID (1)	ID26317A (fr)
IL (1)	IL135457A0 (fr)
MA (1)	MA24691A1 (fr)
NO (1)	NO20002126L (fr)
NZ (1)	NZ504460A (fr)
PA (1)	PA8462501A1 (fr)
PE (1)	PE128699A1 (fr)
PL (1)	PL341141A1 (fr)
PT (1)	PT1028718E (fr)
SK (1)	SK6472000A3 (fr)
SV (1)	SV1998000131A (fr)
TR (1)	TR200001232T2 (fr)
TW (1)	TW555568B (fr)
UA (1)	UA77145C2 (fr)
UY (2)	UY25234A1 (fr)
WO (1)	WO1999022724A2 (fr)
ZA (1)	ZA9810081B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HUP0200898A3 (en) *	1999-04-06	2005-09-28	Sepracor Inc	Derivatives of venlafaxine and methods of preparing and using the same
EP1178780B1 (fr) *	1999-05-20	2007-07-18	ELAN CORPORATION, Plc	Preparations d'inhibiteurs specifiques du recaptage de la serotonine a liberation multiparticulaire regulee
IL146462A (en) *	2001-11-13	2015-02-26	Lycored Bio Ltd	Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
AU2002348266A1 (en) *	2001-12-05	2003-06-23	Wyeth	Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
AU2002247945A1 (en) *	2001-12-13	2003-06-23	Cadila Healthcare Limited	Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof
AU2002217373A1 (en) *	2002-01-03	2003-07-15	Lek Pharmaceutical And Chemical Company D.D.	Controlled release pharmaceutical formulation containing venlafaxine
AU2003219117A1 (en) *	2002-03-28	2003-10-13	Synthon B.V.	Extended release venlafaxine formulations
US20030191347A1 (en) *	2002-03-28	2003-10-09	Rolf Keltjens	Venlafaxine base
WO2003082805A1 (fr)	2002-03-28	2003-10-09	Synthon B.V.	Sels de venlafaxine faiblement solubles dans l'eau
US6717015B2 (en)	2002-03-28	2004-04-06	Synthon Bv	Venlafaxine besylate
FR2845289B1 (fr)	2002-10-04	2004-12-03	Ethypharm Sa	Spheroides, procede de preparation et compositions pharmaceutiques.
CA2415154C (fr) *	2002-12-24	2009-06-16	Biovail Laboratories Inc.	Preparations a liberation modifiee contenant des inhibiteurs selectifs de la recapture de la serotonine
DE10350194B4 (de) *	2003-10-28	2005-11-10	Bioplanta Arzneimittel Gmbh	Verwendung von Extrakten aus Opuntien zur Behandlung von depressiven Verstimmungen und Erkrankungen
TW200503670A (en) *	2003-03-28	2005-02-01	Sandoz Ag	Venlafaxine compositions
ATE336988T1 (de) *	2003-07-30	2006-09-15	Pharmathen Sa	Venlafaxine hydrochloridformulierungen mit verzögerter freisetzung
HUP0303382A2 (hu) *	2003-10-10	2005-08-29	EGIS Gyógyszergyár Rt.	Venlafaxin-hidroklorid-tartalmú pelletek
ATE361743T1 (de)	2004-02-04	2007-06-15	Alembic Ltd	Beschichtete minitabletten von venlafaxinhydrochlorid mit verlängerter freisetzung
US7776358B2 (en)	2004-07-22	2010-08-17	Synthon Ip Inc.	Extended release venlafaxine besylate tablets
EP2010162A4 (fr) *	2006-04-03	2013-01-09	Isa Odidi	Composition d'administration de médicament
WO2007129329A2 (fr) *	2006-05-08	2007-11-15	Jubilant Organosys Limited	Préparation pharmaceutique à libération prolongée comprenant du chlorhydrate de venlafaxine
CN102772390B (zh) *	2012-08-16	2014-01-08	乐普药业股份有限公司	一种盐酸文拉法辛缓释胶囊及其制备方法
FR3080278B1 (fr) *	2018-04-11	2021-04-30	Ghs Patents Ltd	Procede de fabrication d'un spheroide de cannabidiol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1561204A (en) *	1977-06-01	1980-02-13	Ici Ltd	Sustained release pharmaceutical composition
US6440457B1 (en) *	1993-05-27	2002-08-27	Alza Corporation	Method of administering antidepressant dosage form
PE57198A1 (es) *	1996-03-25	1998-10-10	American Home Prod	Formula de liberacion prolongada
ZA97976B (en) *	1996-04-05	1997-08-18	Alza Corp	Uniform drug delivery theraphy.

1998
- 1998-03-11 UA UA2000063197A patent/UA77145C2/uk unknown
- 1998-10-30 PA PA19988462501A patent/PA8462501A1/es unknown
- 1998-11-02 MA MA25330A patent/MA24691A1/fr unknown
- 1998-11-03 EE EEP200000212A patent/EE04577B1/xx not_active IP Right Cessation
- 1998-11-03 CO CO98064480A patent/CO5011060A1/es unknown
- 1998-11-03 DE DE69813602T patent/DE69813602T2/de not_active Revoked
- 1998-11-03 GE GEAP19985388A patent/GEP20043198B/en unknown
- 1998-11-03 KR KR1020007004865A patent/KR20010031797A/ko not_active Ceased
- 1998-11-03 BR BR9813179-6A patent/BR9813179A/pt not_active Application Discontinuation
- 1998-11-03 WO PCT/US1998/023338 patent/WO1999022724A2/fr not_active Ceased
- 1998-11-03 DK DK98956487T patent/DK1028718T3/da active
- 1998-11-03 NZ NZ504460A patent/NZ504460A/xx unknown
- 1998-11-03 HR HR20000213A patent/HRP20000213B1/xx not_active IP Right Cessation
- 1998-11-03 AT AT98956487T patent/ATE237320T1/de not_active IP Right Cessation
- 1998-11-03 TW TW086102797A patent/TW555568B/zh not_active IP Right Cessation
- 1998-11-03 PL PL98341141A patent/PL341141A1/xx not_active Application Discontinuation
- 1998-11-03 SK SK647-2000A patent/SK6472000A3/sk unknown
- 1998-11-03 IL IL13545798A patent/IL135457A0/xx unknown
- 1998-11-03 JP JP2000518658A patent/JP2001521892A/ja active Pending
- 1998-11-03 CN CN98810881A patent/CN1278165A/zh active Pending
- 1998-11-03 TR TR2000/01232T patent/TR200001232T2/xx unknown
- 1998-11-03 AU AU13003/99A patent/AU747978B2/en not_active Ceased
- 1998-11-03 CZ CZ20001659A patent/CZ20001659A3/cs unknown
- 1998-11-03 EA EA200000487A patent/EA200000487A1/ru unknown
- 1998-11-03 HU HU0004287A patent/HU225238B1/hu not_active IP Right Cessation
- 1998-11-03 CA CA002305242A patent/CA2305242A1/fr not_active Abandoned
- 1998-11-03 ES ES98956487T patent/ES2196620T3/es not_active Expired - Lifetime
- 1998-11-03 EP EP98956487A patent/EP1028718B1/fr not_active Revoked
- 1998-11-03 PT PT98956487T patent/PT1028718E/pt unknown
- 1998-11-03 ID IDW20000834A patent/ID26317A/id unknown
- 1998-11-04 ZA ZA9810081A patent/ZA9810081B/xx unknown
- 1998-11-04 SV SV1998000131A patent/SV1998000131A/es not_active Application Discontinuation
- 1998-11-04 AR ARP980105563A patent/AR014012A1/es unknown
- 1998-11-04 PE PE1998001045A patent/PE128699A1/es not_active Application Discontinuation
- 1998-11-05 UY UY25234A patent/UY25234A1/es not_active IP Right Cessation
1999
- 1999-09-03 UY UY25692A patent/UY25692A1/es not_active IP Right Cessation
2000
- 2000-04-26 NO NO20002126A patent/NO20002126L/no not_active Application Discontinuation
- 2000-05-04 BG BG104397A patent/BG104397A/xx unknown
2004
- 2004-07-06 CL CL200401705A patent/CL2004001705A1/es unknown

Also Published As

Publication number	Publication date
PA8462501A1 (es)	2000-05-24
HK1029056A1 (en)	2001-03-23
UY25234A1 (es)	2000-12-29
HU225238B1 (en)	2006-08-28
PT1028718E (pt)	2003-07-31
MA24691A1 (fr)	1999-07-01
HUP0004287A2 (hu)	2002-04-29
EP1028718B1 (fr)	2003-04-16
JP2001521892A (ja)	2001-11-13
AU1300399A (en)	1999-05-24
WO1999022724A2 (fr)	1999-05-14
PE128699A1 (es)	2000-01-06
EE200000212A (et)	2001-04-16
DE69813602T2 (de)	2003-11-06
SK6472000A3 (en)	2000-11-07
CL2004001705A1 (es)	2005-06-03
HRP20000213A2 (en)	2000-12-31
IL135457A0 (en)	2001-05-20
TW555568B (en)	2003-10-01
CO5011060A1 (es)	2001-02-28
UA77145C2 (en)	2006-11-15
NO20002126L (no)	2000-05-04
CZ20001659A3 (cs)	2001-10-17
EA200000487A1 (ru)	2000-10-30
CA2305242A1 (fr)	1999-05-14
AR014012A1 (es)	2001-01-31
HUP0004287A3 (en)	2002-05-28
EP1028718A2 (fr)	2000-08-23
ES2196620T3 (es)	2003-12-16
ZA9810081B (en)	2000-05-04
EE04577B1 (et)	2006-02-15
NZ504460A (en)	2003-01-31
ATE237320T1 (de)	2003-05-15
WO1999022724A3 (fr)	1999-07-22
HRP20000213B1 (en)	2004-04-30
ID26317A (id)	2000-12-14
CN1278165A (zh)	2000-12-27
KR20010031797A (ko)	2001-04-16
PL341141A1 (en)	2001-03-26
TR200001232T2 (tr)	2000-12-21
NO20002126D0 (no)	2000-04-26
GEP20043198B (en)	2004-03-25
DE69813602D1 (de)	2003-05-22
AU747978B2 (en)	2002-05-30
SV1998000131A (es)	1999-11-18
DK1028718T3 (da)	2003-07-28
BR9813179A (pt)	2000-08-22
UY25692A1 (es)	2000-03-31

Publication	Publication Date	Title
NZ504460A (en)	2003-01-31	Sustained release formulations containing venlafaxine
CA2199778A1 (fr)	1997-09-25	Formulation de venlafaxine a liberation prolongee
MY126555A (en)	2006-10-31	Oral pharmaceutical extended release dosage form
NZ333822A (en)	1999-11-29	Tramadol multiple unit formulations comprising individual pellets of trmadol coated with one or more membrane layers for controlling release
AU6136199A (en)	2000-03-27	Dosage form comprising therapeutic formulation
IL116674A (en)	2003-05-29	Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
AU6517596A (en)	1997-02-05	Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors
BR0015188A (pt)	2002-11-05	Composições farmacêuticas
WO1994027589A3 (fr)	1995-01-26	Forme galenique d'un antidepresseur
AU3846901A (en)	2001-08-27	Oral, nasal and pulmonary dosage formualtions of copolymer 1
PT1411921E (pt)	2008-03-12	Composições farmacêuticas contendo terbinafina e suas utilizações
GEP20053501B (en)	2005-05-10	Core Tablet for Controlled Release of Gliclazide after Oral Administration
ATE424810T1 (de)	2009-03-15	Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
IL148777A (en)	2013-10-31	Mirtazepine oral oral administration unit
WO2002062952A3 (fr)	2004-02-12	Mutants pap non cytotoxiques
GEP20043377B (en)	2004-04-13	Pharmaceutical Complex
HRP20000704B1 (hr)	2009-11-30	Peroralni pripravci koji kontrolirano oslobađaju levosimendan
AU4469097A (en)	1998-04-02	Captopril tablets
WO2003105811A8 (fr)	2005-07-21	Compositions a liberation progressive et son procede d'utilisation
BG102638A (bg)	1999-07-30	Таблети с високо съдържание на фамцикловир
ECSP972046A (es)	1998-02-13	Formula de liberacion prolongada
ECSP982704A (es)	1999-04-16	Formula de liberacion prolongada
MX9606041A (es)	1998-02-28	Forma de dosificacion de rapida disolucion.
UA83094C2 (en)	2008-06-10	Tablet of citalopram hydrobromide
TH44960A (th)	2001-04-30	ยาผสมตามสูตรที่ปลดปล่อยยาเป็นระยะยาว